FDA claims Amgen drug data were ‘manipulated’; Erasca slides despite ‘home run’ results
Summary
Tavneos’ original developer hid a study analysis and then altered data, the FDA alleged. Elsewhere, Erasca’s RAS drug was met with skepticism and Rocket Pha...
Description
Tavneos’ original developer hid a study analysis and then altered data, the FDA alleged. Elsewhere, Erasca’s RAS drug was met with skepticism and Rocket Pha...
Original reporting
AFBytes is a read-only aggregator. Use the original source for full context and complete reporting.
Open original source